HCPLive Network

Obama Signs Bill to Encourage Schools to Stock Epinephrine

THURSDAY, Nov. 14 (HealthDay News) -- A new law meant to increase the availability of life-saving epinephrine in US schools was signed Wednesday by President Barack Obama.

Epinephrine can help prevent severe reactions (anaphylaxis) and death in children with severe food allergies. The law provides a financial incentive to states to maintain a supply of epinephrine in their schools and to permit trained school staff to administer it, the Wall Street Journal reported.

Only four states -- Maryland, Nebraska, Nevada, and Virginia -- currently require schools to stock epinephrine, according to the Food Allergy Research & Education organization. Another 20 states permit schools to stock the medication but don't require they do so.

"This is something that will save children's lives," Obama said at a ceremony to sign the bill, WSJ reported.

Full Article

Copyright © 2013 HealthDay. All rights reserved.
Further Reading
As the nation tries to cut its health-care costs critics of reform have worried that some patients who need expensive though risky procedures like coronary artery bypass graft surgery might not get them. But a new Harvard School of Public Health study could allay those fears.
With more people than ever using cell phones, tablets, and other personal technological devices, dermatologists have voiced concerns over the increase in cases of nickel allergies. Nickel, one of the most prevalent allergens in the United States, can be found within most handheld electronic devices and jewelry.
Although hemodialysis is a commonly used treatment for kidney failure, a recent study has shown it may not be as beneficial for people who develop a sudden case of the condition.
Healthcare workers in poor nations often do not have enough protective gear to keep them safe from being infected with blood-borne viruses such as Ebola and HIV, according to a study published online Aug. 8 in Tropical Medicine & International Health.
Para-aortic radiation correlates with increased diabetes mellitus risk for Hodgkin's lymphoma survivors, according to a study published online Aug. 25 in the Journal of Clinical Oncology.
For patients with stiff person syndrome, autologous hematopoietic stem cell transplantation can induce prolonged clinical remission, according to a case report published online Aug. 25 in JAMA Neurology.
Insulin, a peptide hormone, can protect the cells of the pancreas from acute pancreatitis – a disease for which there is currently no cure, according to a study by scientists from The University of Manchester.
More Reading